Not from Advocate Health - Midwest? Click the title link for additional options to access full-text. For best viewing, we recommend Google Chrome.

Follow


Works from 2024

Link

Relevance of Adalimumab product attributes to patient experience in the Biosimilar Era: A narrative review, Jessica R. Allegretti, Jessica H. Brady, Ann Wicker, et al. (Article)

Works from 2022

Ankylosing spondylitis, Abdul Salman Mohammed and Lindsay N. Moy (Book Chapter)

Link

Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naive patients, Alvin F. Wells, Christopher J Edwards, Alan J Kivitz, et al. (Article)

Link

Baseline disease activity predicts achievement of cDAPSA treatment targets with apremilast: Phase 3 results in DMARD-naive patients with psoriatic arthritis, Philip J. Mease, Arthur Kavanaugh, Alexis Ogdie, et al. (Article)

Gout, Sangili Chandran and Ahja D. Steele (Book Chapter)

Link

Telemedicine and psoriatic arthritis: Best practices and considerations for dermatologists and rheumatologists, Alice B. Gottlieb, Alvin F. Wells, and Joseph F. Merola (Article)

Works from 2019

Link

Raynaud's phenomenon manifesting as progressive abnormal MRI bone marrow signal in the toes, Mason A. Brown, Douglas Handley, and Andrew Simon (Article)

Works from 2015

Factors Associated With Time to Diagnosis in Fibromyalgia, Gabriel Chodick, Daliah Weitzman, Yael Bar-On, Varda Shalev, and Howard Amital (Supplement)

Works from 2014

PDF

What Is PFAPA and Why Does it Matter?, Dennis J. Baumgardner (Editorial)

Works from 2005

Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population, Cai Lei, Zhang Dongqing, Shi Yeqing, et al. (Article)